 | Up a level |
Gratwohl, A; Pfirrmann, M; Zander, A; Kröger, N; Beelen, D; Novotny, J; Nerl, C; Scheid, C; Spiekermann, K; Mayer, J; Sayer, H G; Falge, C; Bunjes, D; Döhner, H; Ganser, A; Schmidt-Wolf, I; Schwerdtfeger, R; Baurmann, H; Kuse, R; Schmitz, N; ... (2016). Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment. Leukemia, 30(3), pp. 562-569. Nature Publishing Group 10.1038/leu.2015.281
Borte, M; Horneff, G; Kempf, Christoph; Kaise, R; Korinthenberg, R; Körholz, D; Mauz-Körholz, C; Nadal, D; Niggemann, B; Roos, R; Späth, Peter; Wahn, V; Wehmeier, A; Zepp, F; Zielen, S (2007). Herstellung von intravenös verabreichbaren Immunglobulinen und Pathogensicherheit. In: Wahn, Volker (ed.) Klinischer Einsatz von Immunglobulinen (pp. 28-47). Bremen et al.: UNI-MED
